- AstraZeneca (AZN +0.5%) upgraded to Buy at Liberum.
- Ligand Pharmaceuticals (LGND +4.4%) upgraded to Hold from Sell at Cantor.
- Vivus (VVUS +3.6%) initiated at Hold at WallachBeth.
- Synageva BioPharma (GEVA +5.9%) initiated at Buy at Goldman. Price target is $72 (upside of 37% from Thursday's close).
Next headline on your portfolio: